pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
DR/DME Program
Diabetic Macular Edema
Ceramedix Holding LLC
0
catalysts
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 1
DST-2105
Keratoconjunctivitis Sicca (Dry Eye)
DelSiTech Ltd
0
catalysts
Preclinical
DT-003
Open-Angle Glaucoma
← prev
page 5 of 13
next →
131
Pain
89
Neurology
1
Diorasis Therapeutics
0
catalysts
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
Metabotropic glutamate receptor 4
$DSGN
Design Therapeutics, Inc.
0
catalysts
Phase 1
EB-105
Diabetic Macular Edema
Eluminex Biosciences Ltd
0
catalysts
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
0
catalysts
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
0
catalysts
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
0
catalysts
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
0
catalysts
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
0
catalysts
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
0
catalysts
Phase 1
ER-100
Non-Arteritic Anterior Ischemic Optic Neuropathy
Life Biosciences Inc.
0
catalysts
Preclinical
Emtin-B
Glaucoma
NeuroScientific Biopharmaceuticals Ltd
0
catalysts
Marketed
Eryped
E.E.S. (erythromycin [INN])
Acute Intestinal Amoebiasis
Carnegie Pharmaceuticals LLC
0
catalysts
Preclinical
FLQ-105
Geographic Atrophy
Feliqs Corp
0
catalysts
Marketed
Flarex
Flarex (fluorometholone acetate)
Anterior Segment Inflammation
$HROW
HARROW, INC.
0
catalysts
Preclinical
GF-103
Wet (Neovascular / Exudative) Macular Degeneration
HLB Genex Inc
0
catalysts
Phase 2
GLK-221
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-302
pilocarpine
Presbyopia
Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M3
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-321
Demodex Blepharitis
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-401
Age Related Macular Degeneration
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFS
Grifols SA
0
catalysts
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
0
catalysts
Phase 2
Gene Therapy to Activate Retinoschisin for X-Linked Retinoschisis
Retinal Degeneration
National Eye Institute
0
catalysts
Phase 2
H-1337
Open-Angle Glaucoma
D. Western Therapeutics Institute Inc
0
catalysts
